Claritin joins the $1 bil. club
This article was originally published in The Tan Sheet
Executive Summary
Schering-Plough says sales of the allergy drug have surpassed $1 bil. since moving over the counter at the end of 2002. The success of the antihistamine "solidifies" Schering's "long-standing leadership position" in the Rx-to-OTC switch arena, the firm claims in a March 22 statement...